| Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland–on behalf of the UK national coordinating … M Zaakouk, C Quinn, E Provenzano, C Boyd, G Callagy, S Elsheikh, ... The Breast 70, 82-91, 2023 | 25 | 2023 |
| Diagnostic value of TROP-2 and CK19 expression in papillary thyroid carcinoma in both surgical and cytological specimens AG Abdou, M Shabaan, R Abdallha, N Nabil Clinical pathology 12, 2632010X19863047, 2019 | 24 | 2019 |
| Potential quality pitfalls of digitalized whole slide image of breast pathology in routine practice NM Atallah, MS Toss, C Verrill, M Salto-Tellez, D Snead, EA Rakha Modern Pathology 35 (7), 903-910, 2022 | 22 | 2022 |
| Refining the definition of HER2‐low class in invasive breast cancer NM Atallah, MS Toss, AR Green, NP Mongan, G Ball, EA Rakha Histopathology 81 (6), 770-785, 2022 | 21 | 2022 |
| Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence S Makhlouf, N Wahab, M Toss, A Ibrahim, AG Lashen, NM Atallah, ... British Journal of Cancer 129 (11), 1747-1758, 2023 | 16 | 2023 |
| Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level NM Atallah, M Alsaleem, MS Toss, NP Mongan, E Rakha British Journal of Cancer 129 (10), 1692-1705, 2023 | 16 | 2023 |
| AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancer N Wahab, M Toss, IM Miligy, M Jahanifar, NM Atallah, W Lu, S Graham, ... npj Precision Oncology 7 (1), 122, 2023 | 10 | 2023 |
| Artificial intelligence-based mitosis scoring in breast cancer: clinical application A Ibrahim, M Jahanifar, N Wahab, MS Toss, S Makhlouf, N Atallah, ... Modern Pathology 37 (3), 100416, 2024 | 9 | 2024 |
| AI‐based intra‐tumor heterogeneity score of Ki67 expression as a prognostic marker for early‐stage ER+/HER2− breast cancer W Lu, AG Lashen, N Wahab, IM Miligy, M Jahanifar, M Toss, S Graham, ... The Journal of Pathology: Clinical Research 10 (1), e346, 2024 | 9 | 2024 |
| Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression NM Atallah, M Haque, C Quinn, MS Toss, S Makhlouf, A Ibrahim, ... European Journal of Cancer 195, 113371, 2023 | 9 | 2023 |
| Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance S Makhlouf, C Quinn, M Toss, M Alsaleem, NM Atallah, A Ibrahim, ... European Journal of Cancer 197, 113473, 2024 | 7 | 2024 |
| Deciphering the morphology of tumor-stromal features in invasive breast cancer using artificial intelligence NM Atallah, N Wahab, MS Toss, S Makhlouf, AY Ibrahim, AG Lashen, ... Modern Pathology 36 (10), 100254, 2023 | 6 | 2023 |
| Novel 2 gene signatures associated with breast cancer proliferation: Insights from predictive differential gene expression analysis A Ibrahim, MS Toss, M Alsaleem, S Makhlouf, N Atallah, AR Green, ... Modern Pathology 37 (2), 100403, 2024 | 5 | 2024 |
| Deciphering the clinical behaviour of invasive lobular carcinoma of the breast defines an aggressive subtype S Makhlouf, NM Atallah, S Polotto, AHS Lee, AR Green, EA Rakha Cancers 16 (10), 1893, 2024 | 3 | 2024 |
| Combined proliferation and apoptosis index provides better risk stratification in breast cancer A Ibrahim, MS Toss, NM Atallah, M Al Saleem, AR Green, EA Rakha Histopathology 82 (7), 1029-1047, 2023 | 2 | 2023 |
| THE DIAGNOSTIC VALIDITY OF TROP-2 IN RECOGNIZING PAPILLARY THYROID CARCINOMA N NABIL, A ABDOU, M SHABAN, R ABDALLAH Med. J. Cairo Univ 86 (8), 4349-4355, 2018 | 2* | 2018 |
| Prediction of response to anti-HER2 therapy using a multigene assay N Atallah, S Makhlouf, X Li, Y Zhang, NP Mongan, E Rakha Modern Pathology 38 (4), 100713, 2025 | | 2025 |
| Characterization of Breast Cancer Intra-Tumor Heterogeneity Using Artificial Intelligence AG Lashen, N Wahab, M Toss, I Miligy, S Ghanaam, S Makhlouf, ... Cancers 16 (22), 3849, 2024 | | 2024 |
| Deciphering the Role of ASPM in Breast Cancer: A Comprehensive Multicohort Study A Ibrahim, NM Atallah, S Makhlouf, MS Toss, A Green, E Rakha Cancers 16 (22), 3814, 2024 | | 2024 |
| Prediction of HER2 positive breast cancer patients’ response to anti-HER2 therapy using mRNA level N Atallah, S Makhlouf, XM Li, Y Zhangy, E Rakha European Journal of Cancer 200, 2024 | | 2024 |
